XML 98 R95.htm IDEA: XBRL DOCUMENT v2.4.0.8
GUARANTOR AND NONGUARANTOR FINANCIAL INFORMATION (Details 3) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by operating activities attributable to continuing operations $ 410,961 $ 354,527 $ 372,386
Acquisitions, net of cash acquired (40,690) (411,035) (278,469)
Capital expenditures (80,311) (51,201) (39,954)
Proceeds from maturities and sales of marketable debt securities 12,502 195,501 584,935
Proceeds from sales of long-term investments 69,968 14,194 15,214
Purchases of long-term investments (51,080) (36,094) (90,245)
Other, net 9,594 (9,501) (12,697)
Net cash used in investing activities attributable to continuing operations (80,017) (352,088) (25,186)
Proceeds from issuance of long-term debt 500,000 500,000   
Principal payments on long-term debt (15,844) 0 0
Purchase of treasury stock (264,214) (691,830) (507,765)
Dividends (79,189) (68,163) (10,668)
Issuance of common stock, net of withholding taxes (5,077) 262,841 132,785
Excess tax benefits from stock-based awards 32,891 57,101 22,166
Purchase of noncontrolling Interests (67,947) (4,891) (3,843)
Purchases of marketable debt securities    (53,952) (203,970)
Funds transferred to escrow for Meetic tender offer (71,512) 0 0
Debt issuance Costs (7,399) (11,001) 0
Other, net (3,787) 244 (4,908)
Net cash provided by (used in) financing activities attributable to continuing operations 17,922 44,301 (372,233)
Total cash used in continuing operations 348,866 46,740 (25,033)
Total cash used in discontinued operations (1,877) (3,472) (8,417)
Effect of exchange rate changes on cash and cash equivalents 3,478 2,556 (4,496)
Net increase (decrease) in cash and cash equivalents 350,467 45,824 (37,946)
Cash and cash equivalents at beginning of period 749,977 704,153 742,099
Cash and cash equivalents at end of period 1,100,444 749,977 704,153
IAC
     
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by operating activities attributable to continuing operations (95,081) (116,353) (75,300)
Acquisitions, net of cash acquired 0 (35,159) 0
Capital expenditures (1,387) (3,969) (798)
Proceeds from maturities and sales of marketable debt securities 12,502 195,501 267,635
Proceeds from sales of long-term investments 7,839 14,194 10,214
Purchases of long-term investments (17,814) (27,187) (35,263)
Other, net 0 (351) 0
Net cash used in investing activities attributable to continuing operations 1,140 89,077 167,548
Proceeds from issuance of long-term debt 500,000 500,000  
Principal payments on long-term debt (15,844)    
Purchase of treasury stock (264,214) (691,830) (507,765)
Dividends (79,189) (68,163) (10,668)
Issuance of common stock, net of withholding taxes (5,077) 262,841 132,785
Excess tax benefits from stock-based awards 32,081 52,209 22,166
Purchase of noncontrolling Interests 0 (1,936) (3,843)
Purchases of marketable debt securities   (53,952) (74,240)
Funds transferred to escrow for Meetic tender offer 0    
Debt issuance Costs (7,399) (11,001)  
Intercompany 216,359 (55,020) 824,194
Other, net         
Net cash provided by (used in) financing activities attributable to continuing operations 376,717 (12,900) 456,869
Total cash used in continuing operations 282,776 (40,176) 549,117
Total cash used in discontinued operations (1,829) (3,971) (7,166)
Effect of exchange rate changes on cash and cash equivalents 0 0 3,271
Net increase (decrease) in cash and cash equivalents 280,947 (44,147) 545,222
Cash and cash equivalents at beginning of period 501,075 545,222 0
Cash and cash equivalents at end of period 782,022 501,075 545,222
Guarantor Subsidiaries
     
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by operating activities attributable to continuing operations 537,116 453,692 367,719
Acquisitions, net of cash acquired (6,638) (341,963) (80,998)
Capital expenditures (63,931) (29,550) (29,542)
Proceeds from maturities and sales of marketable debt securities 0 0 0
Proceeds from sales of long-term investments 50,850 0 0
Purchases of long-term investments 0 (724) (51,008)
Other, net (1,725) 117 1,886
Net cash used in investing activities attributable to continuing operations (21,444) (372,120) (159,662)
Proceeds from issuance of long-term debt        
Principal payments on long-term debt 0    
Purchase of treasury stock         
Dividends         
Issuance of common stock, net of withholding taxes         
Excess tax benefits from stock-based awards    4,892   
Purchase of noncontrolling Interests 0 0 0
Purchases of marketable debt securities   0 0
Funds transferred to escrow for Meetic tender offer 0    
Debt issuance Costs 0 0  
Intercompany (514,464) (86,446) (207,950)
Other, net (1,225)    (249)
Net cash provided by (used in) financing activities attributable to continuing operations (515,689) (81,554) (208,199)
Total cash used in continuing operations (17) 18 (142)
Total cash used in discontinued operations         
Effect of exchange rate changes on cash and cash equivalents 17 (18) 142
Net increase (decrease) in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period 0 0 0
Non-Guarantor Subsidiaries
     
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by operating activities attributable to continuing operations (31,074) 17,188 79,967
Acquisitions, net of cash acquired (34,052) (33,913) (197,471)
Capital expenditures (14,993) (17,682) (9,614)
Proceeds from maturities and sales of marketable debt securities 0 0 317,300
Proceeds from sales of long-term investments 11,279 0 5,000
Purchases of long-term investments (33,266) (8,183) (3,974)
Other, net 11,319 (9,267) (14,583)
Net cash used in investing activities attributable to continuing operations (59,713) (69,045) (33,072)
Proceeds from issuance of long-term debt        
Principal payments on long-term debt 0    
Purchase of treasury stock         
Dividends         
Issuance of common stock, net of withholding taxes         
Excess tax benefits from stock-based awards 810      
Purchase of noncontrolling Interests (67,947) (2,955) 0
Purchases of marketable debt securities   0 (129,730)
Funds transferred to escrow for Meetic tender offer (71,512)    
Debt issuance Costs 0 0  
Intercompany 298,105 141,466 (616,244)
Other, net (2,562) 244 (4,659)
Net cash provided by (used in) financing activities attributable to continuing operations 156,894 138,755 (620,903)
Total cash used in continuing operations 66,107 86,898 (574,008)
Total cash used in discontinued operations (48) 499 (1,251)
Effect of exchange rate changes on cash and cash equivalents 3,461 2,574 (7,909)
Net increase (decrease) in cash and cash equivalents 69,520 89,971 (583,168)
Cash and cash equivalents at beginning of period 248,902 158,931 742,099
Cash and cash equivalents at end of period 318,422 248,902 158,931
Total Eliminations
     
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by operating activities attributable to continuing operations 0 0 0
Acquisitions, net of cash acquired 0 0 0
Capital expenditures 0 0 0
Proceeds from maturities and sales of marketable debt securities 0 0 0
Proceeds from sales of long-term investments 0 0 0
Purchases of long-term investments 0 0 0
Other, net 0 0 0
Net cash used in investing activities attributable to continuing operations 0 0 0
Proceeds from issuance of long-term debt 0 0  
Principal payments on long-term debt 0    
Purchase of treasury stock 0 0 0
Dividends 0 0 0
Issuance of common stock, net of withholding taxes 0 0 0
Excess tax benefits from stock-based awards 0 0 0
Purchase of noncontrolling Interests 0 0 0
Purchases of marketable debt securities   0 0
Funds transferred to escrow for Meetic tender offer 0    
Debt issuance Costs 0 0  
Intercompany 0 0 0
Other, net 0 0 0
Net cash provided by (used in) financing activities attributable to continuing operations 0 0 0
Total cash used in continuing operations 0 0 0
Total cash used in discontinued operations 0 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net increase (decrease) in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period 0 0 0
IAC Consolidated
     
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by operating activities attributable to continuing operations 410,961 354,527 372,386
Acquisitions, net of cash acquired (40,690) (411,035) (278,469)
Capital expenditures (80,311) (51,201) (39,954)
Proceeds from maturities and sales of marketable debt securities 12,502 195,501 584,935
Proceeds from sales of long-term investments 69,968 14,194 15,214
Purchases of long-term investments (51,080) (36,094) (90,245)
Other, net 9,594 (9,501) (12,697)
Net cash used in investing activities attributable to continuing operations (80,017) (352,088) (25,186)
Proceeds from issuance of long-term debt 500,000 500,000  
Principal payments on long-term debt (15,844)    
Purchase of treasury stock (264,214) (691,830) (507,765)
Dividends (79,189) (68,163) (10,668)
Issuance of common stock, net of withholding taxes (5,077) 262,841 132,785
Excess tax benefits from stock-based awards 32,891 57,101 22,166
Purchase of noncontrolling Interests (67,947) (4,891) (3,843)
Purchases of marketable debt securities   (53,952) (203,970)
Funds transferred to escrow for Meetic tender offer (71,512)    
Debt issuance Costs (7,399) (11,001)  
Intercompany 0 0 0
Other, net (3,787) 244 (4,908)
Net cash provided by (used in) financing activities attributable to continuing operations 17,922 44,301 (372,233)
Total cash used in continuing operations 348,866 46,740 (25,033)
Total cash used in discontinued operations (1,877) (3,472) (8,417)
Effect of exchange rate changes on cash and cash equivalents 3,478 2,556 (4,496)
Net increase (decrease) in cash and cash equivalents 350,467 45,824 (37,946)
Cash and cash equivalents at beginning of period 749,977 704,153 742,099
Cash and cash equivalents at end of period $ 1,100,444 $ 749,977 $ 704,153